
John S. Brusca
Examiner (ID: 15745)
| Most Active Art Unit | 1631 |
| Art Unit(s) | 1636, 1631, 1805, 1672, 1621 |
| Total Applications | 1495 |
| Issued Applications | 870 |
| Pending Applications | 179 |
| Abandoned Applications | 449 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3769296
[patent_doc_number] => 05756341
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-26
[patent_title] => 'Method for controlling the infectivity of viruses'
[patent_app_type] => 1
[patent_app_number] => 8/483522
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11824
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/756/05756341.pdf
[firstpage_image] =>[orig_patent_app_number] => 483522
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/483522 | Method for controlling the infectivity of viruses | Jun 6, 1995 | Issued |
Array
(
[id] => 483814
[patent_doc_number] => 07220854
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-22
[patent_title] => 'Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides'
[patent_app_type] => utility
[patent_app_number] => 08/486066
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14472
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/220/07220854.pdf
[firstpage_image] =>[orig_patent_app_number] => 08486066
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486066 | Sugar moiety labeled nucleotide, and an oligo- or polynucleotide, and other compositions comprising such sugar moiety labeled nucleotides | Jun 6, 1995 | Issued |
Array
(
[id] => 3657096
[patent_doc_number] => 05627055
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-06
[patent_title] => 'Finderons and methods of their preparation and use'
[patent_app_type] => 1
[patent_app_number] => 8/475867
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 8787
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/627/05627055.pdf
[firstpage_image] =>[orig_patent_app_number] => 475867
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/475867 | Finderons and methods of their preparation and use | Jun 6, 1995 | Issued |
Array
(
[id] => 7724135
[patent_doc_number] => 08097405
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2012-01-17
[patent_title] => 'Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs'
[patent_app_type] => utility
[patent_app_number] => 08/486069
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 14660
[patent_no_of_claims] => 198
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/097/08097405.pdf
[firstpage_image] =>[orig_patent_app_number] => 08486069
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/486069 | Nucleic acid sequencing processes using non-radioactive detectable modified or labeled nucleotides or nucleotide analogs, and other processes for nucleic acid detection and chromosomal characterization using such non-radioactive detectable modified or labeled nucleotides or nucleotide analogs | Jun 6, 1995 | Issued |
Array
(
[id] => 3734877
[patent_doc_number] => 05753262
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Cationic lipid acid salt of 3beta›N- (N\', N\'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof'
[patent_app_type] => 1
[patent_app_number] => 8/485866
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8295
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753262.pdf
[firstpage_image] =>[orig_patent_app_number] => 485866
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485866 | Cationic lipid acid salt of 3beta›N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof | Jun 6, 1995 | Issued |
Array
(
[id] => 3607112
[patent_doc_number] => 05589362
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-31
[patent_title] => 'Tetracycline regulated transcriptional modulators with altered DNA binding specificities'
[patent_app_type] => 1
[patent_app_number] => 8/485971
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 37879
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/589/05589362.pdf
[firstpage_image] =>[orig_patent_app_number] => 485971
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/485971 | Tetracycline regulated transcriptional modulators with altered DNA binding specificities | Jun 6, 1995 | Issued |
Array
(
[id] => 4021768
[patent_doc_number] => 05925564
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-07-20
[patent_title] => 'Expression vector systems and method of use'
[patent_app_type] => 1
[patent_app_number] => 8/472809
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 24002
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/925/05925564.pdf
[firstpage_image] =>[orig_patent_app_number] => 472809
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/472809 | Expression vector systems and method of use | Jun 6, 1995 | Issued |
Array
(
[id] => 4106102
[patent_doc_number] => 06022745
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-08
[patent_title] => 'Homologously recombinant slow growing mycobacteria and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/471869
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 10258
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/022/06022745.pdf
[firstpage_image] =>[orig_patent_app_number] => 471869
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/471869 | Homologously recombinant slow growing mycobacteria and uses therefor | Jun 6, 1995 | Issued |
Array
(
[id] => 3738373
[patent_doc_number] => 05753489
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-05-19
[patent_title] => 'Method for producing viruses and vaccines in serum-free culture'
[patent_app_type] => 1
[patent_app_number] => 8/487046
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11827
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/753/05753489.pdf
[firstpage_image] =>[orig_patent_app_number] => 487046
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/487046 | Method for producing viruses and vaccines in serum-free culture | Jun 6, 1995 | Issued |
Array
(
[id] => 783026
[patent_doc_number] => 06992180
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-01-31
[patent_title] => 'Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides'
[patent_app_type] => utility
[patent_app_number] => 08/479997
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 26722
[patent_no_of_claims] => 116
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/992/06992180.pdf
[firstpage_image] =>[orig_patent_app_number] => 08479997
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479997 | Oligo- or polynucleotides comprising phosphate-moiety labeled nucleotides | Jun 6, 1995 | Issued |
Array
(
[id] => 10097994
[patent_doc_number] => 09134302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Analyte detection utilizing polynucleotide sequences, composition, process and kit'
[patent_app_type] => utility
[patent_app_number] => 08/479995
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12196
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 08479995
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/479995 | Analyte detection utilizing polynucleotide sequences, composition, process and kit | Jun 6, 1995 | Issued |
Array
(
[id] => 3947918
[patent_doc_number] => 05955331
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Recombinant retroviruses with amphotropic and ecotropic host ranges'
[patent_app_type] => 1
[patent_app_number] => 8/488421
[patent_app_country] => US
[patent_app_date] => 1995-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7287
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955331.pdf
[firstpage_image] =>[orig_patent_app_number] => 488421
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/488421 | Recombinant retroviruses with amphotropic and ecotropic host ranges | Jun 6, 1995 | Issued |
| 08/477354 | PEPTIDE-ENHANCED CATIONIC LIPID TRANSFECTIONS | Jun 6, 1995 | Abandoned |
Array
(
[id] => 3993418
[patent_doc_number] => 05858362
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-12
[patent_title] => 'Conjugate vaccine for group B Streptococcus'
[patent_app_type] => 1
[patent_app_number] => 8/466210
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 26400
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/858/05858362.pdf
[firstpage_image] =>[orig_patent_app_number] => 466210
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466210 | Conjugate vaccine for group B Streptococcus | Jun 5, 1995 | Issued |
Array
(
[id] => 3622037
[patent_doc_number] => 05612193
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-03-18
[patent_title] => 'Translation of mRNA'
[patent_app_type] => 1
[patent_app_number] => 8/467926
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 37
[patent_no_of_words] => 8846
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/612/05612193.pdf
[firstpage_image] =>[orig_patent_app_number] => 467926
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/467926 | Translation of mRNA | Jun 5, 1995 | Issued |
Array
(
[id] => 3725799
[patent_doc_number] => 05702898
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-12-30
[patent_title] => 'Procedure for normalization of cDNA libraries'
[patent_app_type] => 1
[patent_app_number] => 8/465857
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5161
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/702/05702898.pdf
[firstpage_image] =>[orig_patent_app_number] => 465857
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/465857 | Procedure for normalization of cDNA libraries | Jun 5, 1995 | Issued |
Array
(
[id] => 3753786
[patent_doc_number] => 05843444
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-01
[patent_title] => 'Conjugate vaccine for group B streptococcus'
[patent_app_type] => 1
[patent_app_number] => 8/470445
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 14
[patent_no_of_words] => 26397
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/843/05843444.pdf
[firstpage_image] =>[orig_patent_app_number] => 470445
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/470445 | Conjugate vaccine for group B streptococcus | Jun 5, 1995 | Issued |
Array
(
[id] => 1408284
[patent_doc_number] => 06528314
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-04
[patent_title] => 'Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made'
[patent_app_type] => B1
[patent_app_number] => 08/466539
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9552
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/528/06528314.pdf
[firstpage_image] =>[orig_patent_app_number] => 08466539
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/466539 | Procedure for specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made | Jun 5, 1995 | Issued |
Array
(
[id] => 3772235
[patent_doc_number] => 05773600
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-30
[patent_title] => 'DNA encoding pertussis toxin muteins'
[patent_app_type] => 1
[patent_app_number] => 8/468679
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 22
[patent_no_of_words] => 9261
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/773/05773600.pdf
[firstpage_image] =>[orig_patent_app_number] => 468679
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468679 | DNA encoding pertussis toxin muteins | Jun 5, 1995 | Issued |
Array
(
[id] => 4038386
[patent_doc_number] => 05856459
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Oligonucleotides specific for hepatitis B virus'
[patent_app_type] => 1
[patent_app_number] => 8/468352
[patent_app_country] => US
[patent_app_date] => 1995-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 14836
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856459.pdf
[firstpage_image] =>[orig_patent_app_number] => 468352
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/468352 | Oligonucleotides specific for hepatitis B virus | Jun 5, 1995 | Issued |